On September 10, 2020 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") reported that its Chairman and Chief Executive Officer Sandesh Seth will be presenting at the virtual H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14th at 2:00 PM EST (Press release, Actinium Pharmaceuticals, SEP 10, 2020, View Source [SID1234564954]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(PRNewsfoto/Actinium Pharmaceuticals, Inc.)

Presentation details are as follows:

Event:

H.C. Wainwright 22nd Annual Global Investment Conference

Date:

Monday, September 14TH

Time:

2:00 PM EST

The presentation will be accessible on the investor relations section of Actinium Pharmaceuticals website at www.actiniumpharma.com